Oppenheimer Starts MediWound Ltd (MDWD) at Outperform
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/1/2026
- Wall Street ends higher as Amazon soothes AI jitters
- Amazon shares rally as cloud growth surges and spending outlook climbs
- Apple shares sink on disappointing September quarter sales outlook
- Novo Nordisk stock tumbles 10% as key trial misses goal
- AI wizkid Leopold Aschenbrenner forced to sell entire portfolio after rout
- SCYNEXIS (SCYX) Move Attributed to Morning Note from Brookline
- AbbVie (ABBV) Misses Q2 EPS by 6c, Beats on Revenue; Offers FY26 EPS Guidance
- Novo Nordisk's ziltivekimab fails to reduce heart risk in ZEUS trial
- Wall Street ends higher as Amazon soothes AI jitters
- Short sellers pile into SpaceX ahead of earnings, lockup expiration
- After-Hours Stock Movers: AAPL, AMZN, COIN, RBLX, RDDT, AXTI, FND, WU, GDDY
- After-Hours Stock Movers: META, MSFT, CMG, SBUX, CVNA, LRCX, FTNT, QCOM, TDOC
- After-Hours Stock Movers: F, BE, STX, WDC, KLAC, SWKS, NXPI, CSGP, ENPH
- After-Hours Stock Movers: FFIV, CDNS, APLD, RMBS, ESI, SANM
- After-Hours Stock Movers: INTC, AMD, ARM, MXL, EW, DECK
BMO Capital Starts MediWound Ltd (MDWD) at Outperform
April 14, 2014 8:58 AM EDTBMO Capital initiated coverage on MediWound Ltd (NASDAQ: MDWD) with an Outperform rating and a price target of $20.00.
For an analyst ratings summary and ratings history on MediWound Ltd click here. For more ratings news on MediWound Ltd click here.
Shares of MediWound Ltd closed at $11.71 yesterday.
... MoreCredit Suisse Starts MediWound Ltd (MDWD) at Outperform
April 14, 2014 8:57 AM EDTCredit Suisse initiated coverage on MediWound Ltd (NASDAQ: MDWD) with an Outperform rating and a price target of $18.00.
For an analyst ratings summary and ratings history on MediWound Ltd click here. For more ratings news on MediWound Ltd click here.
Shares of MediWound Ltd closed at $11.71 yesterday.
... MoreJefferies Starts MediWound Ltd (MDWD) at Buy
April 14, 2014 6:39 AM EDTJefferies initiates coverage on MediWound Ltd (NASDAQ: MDWD) with a Buy rating and a price target of $19.00.
Analyst Raj Denhoy comments, "MediWounds NexoBrid is a novel and potentially disruptive technology in the treatment of severe burns. By reducing the time, cost, and... More
